• by Katie Neville
  • 27-Apr-2020 09:30

LCTC are following guidance released by HRA, MHRA and UKCRC registered CTU network.

LCTC are following guidance released by HRA, MHRA and UKCRC registered CTU network. All trials have been assessed regarding participant safety, trial integrity and their continuation. We are centrally co-ordinating information received from participating trusts and sites. We will continue to monitor this situation and any changes at a trial level will be communicated to sponsors and sites as necessary.

MHRA Website
FDA: "FDA Guidance on Conduct of Clinical Trials of Medicinal Products during COVID-19 Public Health Emergency"
EMA - COVID clinical trial general guidance (published): "Guidance on the Management of Clinical Trials during the COVID-19 Coronavirus) pandemic"
EMA COVID clinical trial methodological guidance (public consultation) - "Implications of coronavirus disease (COVID-19) on methodological aspects of ongoing clinical trials"


COVID - 19 Other Guidance Links

NIHR Statement
Author: Katie Neville
Categories: Trial Related
Tags: Important
Share this article
Other news
Clinical Directorate Newsletter

On International Clinical Trials Day LCTC has taken over the Clinical Directorate Newsletter.

Celebrate International Clinical Trials Day - May 20th 2021

The LCTC team have taken some well-deserved ‘time out’ to celebrate Clinical Trials Day.

LCTC Celebrating Success Event -14th June 2021

As part of the celebrations to mark International Clinical Trials Day the LCTC will be hosting an event to showcase the results of recently completed trials.

Breast Cancer Patient share’s experience of clinical research

The LCTC talk to one of our Patient Representatives, Lesley, about her experiences of clinical research after her diagnosis of Cancer.